NCT03776773

Brief Summary

It has been demonstrated that allergic rhinitis (AR) reduces sleep quality by some components such as nasal obstruction. Pollution and allergen exposure worsening AR, sleep quality is deteriorated. Sleep is associated to physical and mental health, alterations in sleep could explain the link between AR and work productivity diminution, impairment in daily activities or emotional problems. However, interactions between air pollution, sleep and allergic diseases are insufficiently understood. The main objective of this study is to determine the impact of pollution and pollens on sleep parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 17, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

April 8, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2020

Completed
Last Updated

March 13, 2020

Status Verified

March 1, 2020

Enrollment Period

10 months

First QC Date

December 13, 2018

Last Update Submit

March 12, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Impact of pollution on sleep

    Change in AHI according to the level of pollution particle matters and volatile organic compounds (VOCs)

    6 days

Secondary Outcomes (3)

  • The impact of pollution and pollens on sleep quality in patients with AR.

    6 days

  • The impact of pollution on life quality

    6 days

  • To analyze variations in medications and impact on sleep during the pollen season and outside the pollen season.

    6 days

Study Arms (4)

patients AR (+) and sleep apnea (+)

ACTIVE COMPARATOR

Patients with AR and obstructive sleep apnea (OSA) will have sleep and pollution exposure recordings

Other: Pollution exposure

AR (-) and sleep apnea (+)

ACTIVE COMPARATOR

Patients without allergic rhinitis (+ sleep apnea) will have sleep and pollution exposure recordings

Other: Pollution exposure

AR (+) and sleep apnea (-)

ACTIVE COMPARATOR

Patients with allergic rhinitis but no sleep apnea will have sleep and pollution exposure recordings

Other: Pollution exposure

AR (-) and sleep apnea (-)

SHAM COMPARATOR

Volunteers without allergic rhinitis and no sleep apnea will have sleep and pollution exposure recordings

Other: Pollution exposure

Interventions

Pollution exposure and sleep data will be recorded by pollution sensor and polysomnography respectively. In order to compare the variations according to the pollinisation season and the allergic rhinitis status of the patients.

AR (+) and sleep apnea (-)AR (-) and sleep apnea (+)AR (-) and sleep apnea (-)patients AR (+) and sleep apnea (+)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years
  • Be able to use an application on a personal smartphone
  • Patient non treated for OSA
  • Be legally able to give consent
  • Person affiliated to social security

You may not qualify if:

  • \- Being unable to understand, follow objectives and methods due to cognition or language problems Subjects listed in articles L1121-5 à L1121-8: Pregnant women, feeding and parturient; subject under administrative or judicial control, persons who are protected under the act.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Grenoble

Grenoble, France

Location

MeSH Terms

Conditions

Sleep Apnea SyndromesRhinitis, Allergic

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesRhinitisNose DiseasesRespiratory HypersensitivityOtorhinolaryngologic DiseasesHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Jean-Louis PEPIN

    University Hospital, Grenoble

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Prospective, open study comparing sleep quality in 2 different groups: AR patients and patients without AR during the pollen season and outside the pollen season.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2018

First Posted

December 17, 2018

Study Start

April 8, 2019

Primary Completion

January 25, 2020

Study Completion

January 25, 2020

Last Updated

March 13, 2020

Record last verified: 2020-03

Locations